Clinical Trials Logo
  1. Home
  2. Other
  3. NCT05170269

Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion) — PreCyssion  

Congenital Cytomegalovirus Infection Clinical Trial

Official title:
Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection With Gestational Age ≤ 14 Weeks - an Open-label, Single-arm, Prospective Trial Investigating Efficacy and Safety of Cytotect CP Biotest

Clinical Trial Summary

A phase 3, open-label, single-arm, prospective, multi-center trial of Cytotect CP Biotest (BT097) for prevention of maternal-fetal CMV transmission after primary maternal CMV infection. The main purpose of the trial is to demonstrate efficacy and safety of Cytotect CP Biotest in preventing maternal-fetal transmission of cytomegalovirus (CMV).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05170269
Study type Interventional
Source Biotest
Contact
Status Active, not recruiting
Phase Phase 3
Start date November 17, 2021
Completion date August 31, 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT01923636 - Prognostic Value of Neonatal Markers for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus in Utero N/A
Recruiting NCT03973359 - Epidemiology and Prevention of Congenital HCMV in Immune Mothers. Congenital HCMV Infection Lombardy N/A
Completed NCT02005822 - Congenital Cytomegalovirus: Efficacy of Antiviral Treatment Phase 3
Completed NCT02139423 - Diagnosis of Congenital CMV Infection in Neonates Who Failed Newborn Hearing Screening N/A
Completed NCT02351102 - Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregnancy Phase 2/Phase 3
Withdrawn NCT02594566 - Safety, Tolerability, and Immunogenicity of a Cytomegalovirus DNA Vaccine Phase 1
Not yet recruiting NCT06118515 - A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus Phase 1
Completed NCT02782988 - Assesment of Olfactory Disorders and Performance of a New Olfactory Test in Children With Congenital CMV
Completed NCT02645396 - A Cohort Study of Congenital Cytomegalovirus Infection Among Pregnant Women and Their Newborns in China
Terminated NCT01655212 - Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial Phase 3
Completed NCT02710864 - A Cross-sectional Study of Congenital Cytomegalovirus Infection in Newborns in China
Completed NCT05754879 - Diagnosis of Congenital Cytomegalovirus Infection in Newborn With Particular Risk
Terminated NCT03301415 - Asymptomatic Congenital CMV Treatment Phase 2
Completed NCT01376778 - A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV) Phase 3